发明名称 Benzyl sulfonamide compounds useful as MoGAT-2 inhibitors
摘要 The present invention provides compounds of Formula I. Wherein R1, L, and A are as described herein, or a pharmaceutical salt thereof, processes for preparing the compounds, and methods of treating a condition, such as hypertriglyceridemia, using the compounds.;
申请公布号 US9416138(B2) 申请公布日期 2016.08.16
申请号 US201314438435 申请日期 2013.10.30
申请人 Eli Lilly and Company 发明人 Agejas-Chicharro Francisco Javier;Diaz Buezo Nuria;Gruber Joseph Michael;Stack Douglas Richard
分类号 C07D207/00;C07D491/056;C07D273/00;C07D309/04;C07D311/58;C07D311/76;C07D217/24;C07D319/12;C07D319/20;C07D263/58;C07D491/052;C07D265/30;C07D265/36;C07D207/14;C07D307/22;C07D307/79;C07D309/00;C07D311/00;C07D217/00;C07D319/00;C07D263/00;C07D307/00;C07D307/87 主分类号 C07D207/00
代理机构 代理人 Myers James B.
主权项 1. A compound of the formula below: wherein L is selected from: —CH2—, and —CH2CH2—; R1 is selected from: —CH3 and —CF3; A is selected from: wherein, T is selected from: CH2, NH, and O; U is selected from: CH2, NH, and O; V is selected from: CH2, C═O, NH, N—CH3, and O; provided that at least one but not all of T, U, and V are CH2, and when U is O then each of T and V is other than O or N; W is selected from: CH2 and O; X is selected from: CH and N; provided that when W is CH2, X is N and when W is O, X is CH; Y is selected from: CH2, N—C6H5, and O; Z is selected from CH2 and O: R2 is selected from: H and halogen; R3 is selected from: H, cyclopropyl, and phenyl; R4 is selected from H and phenyl; wherein identifies the bond attaching A to L; and pharmaceutically acceptable salts thereof.
地址 Indianapolis IN US